Biotricity, Inc.
NASDAQ:BTCY
0.3371 (USD) • At close April 2, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 13.79 | 12.063 | 9.639 | 7.65 | 3.385 | 1.418 | 0.398 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 3.226 | 3.707 | 4.197 | 3.08 | 2.112 | 0.932 | 0.338 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 10.564 | 8.356 | 5.442 | 4.57 | 1.273 | 0.486 | 0.06 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.766 | 0.693 | 0.565 | 0.597 | 0.376 | 0.343 | 0.15 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 2.156 | 2.572 | 3.23 | 2.745 | 2.059 | 1.363 | 1.309 | 1.763 | 1.138 | 1.143 | 0.023 | 0.054 |
| General & Administrative Expenses
| 10.858 | 14.613 | 17.622 | 18.562 | 12.565 | 10.053 | 7.343 | 5.961 | 4.804 | 3.987 | 0.056 | 0.029 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 10.858 | 14.613 | 17.622 | 18.562 | 12.565 | 10.053 | 7.343 | 5.961 | 4.804 | 3.987 | 0.056 | 0.029 |
| Other Expenses
| 0 | 0 | 0 | 0 | -0.648 | 0 | 0 | 0 | 0 | 0 | -0.001 | -0.001 |
| Operating Expenses
| 13.013 | 17.185 | 20.852 | 21.307 | 13.977 | 11.416 | 8.652 | 7.724 | 5.942 | 5.13 | 0.09 | 0.09 |
| Operating Income
| -2.449 | -8.828 | -15.41 | -16.737 | -13.2 | -10.914 | -8.592 | -7.724 | -5.942 | -5.13 | -0.09 | -0.091 |
| Operating Income Ratio
| -0.178 | -0.732 | -1.599 | -2.188 | -3.9 | -7.698 | -21.577 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -5.972 | -5.266 | -3.248 | -12.394 | -2.291 | -0.136 | 0 | -0.9 | -1.867 | -0.056 | 0 | 0 |
| Income Before Tax
| -8.421 | -14.094 | -18.658 | -29.13 | -15.491 | -11.067 | -8.592 | -8.624 | -7.809 | -5.186 | -0.091 | -0.091 |
| Income Before Tax Ratio
| -0.611 | -1.168 | -1.936 | -3.808 | -4.577 | -7.806 | -21.577 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 0 | 9.429 | 0 | -0.039 | 0 | 0 | 0 | 0.051 | -0.001 | 0 |
| Net Income
| -8.421 | -14.094 | -18.658 | -29.13 | -15.491 | -11.067 | -8.592 | -8.624 | -7.809 | -5.186 | -0.091 | -0.091 |
| Net Income Ratio
| -0.611 | -1.168 | -1.936 | -3.808 | -4.577 | -7.806 | -21.577 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.55 | -1.66 | -2.26 | -3.99 | -2.63 | -1.85 | -1.54 | -1.72 | -1.81 | -1.42 | -0.061 | -0.061 |
| EPS Diluted
| -0.55 | -1.66 | -2.26 | -3.99 | -2.63 | -1.85 | -1.54 | -1.72 | -1.81 | -1.42 | -0.061 | -0.061 |
| EBITDA
| -3.213 | -8.897 | -16.07 | -16.734 | -12.511 | -10.931 | -8.592 | 0 | -5.942 | -5.121 | 0 | -0.09 |
| EBITDA Ratio
| -0.233 | -0.737 | -1.667 | -2.187 | -3.696 | -7.71 | -21.577 | 0 | 0 | 0 | 0 | 0 |